Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Claude de Montigny
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Anatomy
Chemicals & Drugs
Occupations
Physiology
Procedures
Sign-in to see full Profile
Network (preview)
76
Blier, Pierre
33
Debonnel, Guy
11
Haddjeri, Nasser
10
Chaput, Yves
7
Béïque, Jean-Claude
4
Hébert, Chantal
3
Lavoie, Normand
3
Rueter, LE
3
Dong, J
3
Fournier, Alain
2
Quirion, Rémi
2
Szabo, Steven
2
Benkelfat, Chawki
2
Bergeron, R
1
Diksic, Mirko
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Claude de Montigny (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Blier Pierre; Gobbi Gabriella; Turcotte Julie E; de Montigny Claude; Boucher Nathalie; Hébert Chantal; Debonnel Guy
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2009;19(7):457-65.
-
2007: Weiss Michel; Blier Pierre; de Montigny Claude
Effect of long-term administration of the antidepressant drug milnacipran on serotonergic and noradrenergic neurotransmission in the rat hippocampus.
Life sciences 2007;81(2):166-76.
-
2007: Debonnel Guy; Saint-André Elise; Hébert Chantal; de Montigny Claude; Lavoie Normand; Blier Pierre
Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(1):51-61.
-
2007: Blier Pierre; Saint-André Elise; Hébert Chantal; de Montigny Claude; Lavoie Normand; Debonnel Guy
Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(1):41-50.
-
2001: Turcotte J E; Debonnel G; de Montigny C; Hébert C; Blier P
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):511-21.
-
2000: Béïque J C; Blier P; de Montigny C; Debonnel G
Potentiation by (-)Pindolol of the activation of postsynaptic 5-HT(1A) receptors induced by venlafaxine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;23(3):294-306.
-
2000: Béïque J; de Montigny C; Blier P; Debonnel G
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
Neuropharmacology 2000;39(10):1813-22.
-
2000: Béïque J; de Montigny C; Blier P; Debonnel G
Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
Neuropharmacology 2000;39(10):1800-12.
-
2000: Besson A; Haddjeri N; Blier P; de Montigny C
Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2000;10(3):177-88.
-
2000: Haddjeri N; Szabo S T; de Montigny C; Blier P
Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2000;22(4):346-56.
-
1999: Dong J; De Montigny C; Blier P
Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
Synapse (New York, N.Y.) 1999;34(4):277-89.
-
1999: de Montigny C; Silverstone P H; Debonnel G; Blier P; Bakish D
Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial.
Journal of clinical psychopharmacology 1999;19(5):401-6.
-
1999: Haddjeri N; Ortemann C; de Montigny C; Blier P
Effect of sustained administration of the 5-HT1A receptor agonist flesinoxan on rat 5-HT neurotransmission.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1999;9(5):427-40.
-
1999: Bergeron R; de Montigny C; Debonnel G
Pregnancy reduces brain sigma receptor function.
British journal of pharmacology 1999;127(8):1769-76.
-
1999: Blier P; de Montigny C
Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(2 Suppl):91S-98S.
-
1999: Béïque J C; de Montigny C; Blier P; Debonnel G
Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
Synapse (New York, N.Y.) 1999;32(3):198-211.
-
1999: Haddjeri N; de Montigny C; Blier P
Modulation of the firing activity of rat serotonin and noradrenaline neurons by (+/-)pindolol.
Biological psychiatry 1999;45(9):1163-9.
-
1999: Szabo S T; de Montigny C; Blier P
Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers.
British journal of pharmacology 1999;126(3):568-71.
-
1998: Haddjeri N; Blier P; de Montigny C
Acute and long-term actions of the antidepressant drug mirtazapine on central 5-HT neurotransmission.
Journal of affective disorders 1998;51(3):255-66.
-
1998: Béïque J C; Debonnel G; de Montigny C; Blier P
Discrepancies between the in vitro and in vivo 5-HT and norepinephrine re-uptake blocking properties of venlafaxine.
Annals of the New York Academy of Sciences 1998;861():290-1.
-
1998: Blier P; Piñeyro G; el Mansari M; Bergeron R; de Montigny C
Role of somatodendritic 5-HT autoreceptors in modulating 5-HT neurotransmission.
Annals of the New York Academy of Sciences 1998;861():204-16.
-
1998: Haddjeri N; Blier P; de Montigny C
Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1998;18(23):10150-6.
-
1998: Haddjeri N; Seletti B; Gilbert F; de Montigny C; Blier P
Effect of ergotamine on serotonin-mediated responses in the rodent and human brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(5):365-80.
-
1998: Béïque J C; de Montigny C; Blier P; Debonnel G
Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
British journal of pharmacology 1998;125(3):526-32.
-
1998: Blier P; de Montigny C
Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
Biological psychiatry 1998;44(5):313-23.
-
1998: Dong J; de Montigny C; Blier P
Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
The Journal of pharmacology and experimental therapeutics 1998;286(3):1239-47.
-
1998: Rueter L E; de Montigny C; Blier P
In vivo electrophysiological assessment of the agonistic properties of flibanserin at pre- and postsynaptic 5-HT1A receptors in the rat brain.
Synapse (New York, N.Y.) 1998;29(4):392-405.
-
1998: Mongeau R; Weiss M; de Montigny C; Blier P
Effect of acute, short- and long-term milnacipran administration on rat locus coeruleus noradrenergic and dorsal raphe serotonergic neurons.
Neuropharmacology 1998;37(7):905-18.
-
1998: Rueter L E; Kasamo K; de Montigny C; Blier P
Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1998;357(6):600-10.
-
1998: Béïque J C; Lavoie N; de Montigny C; Debonnel G
Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
European journal of pharmacology 1998;349(1):129-32.
-
1998: Rueter L E; De Montigny C; Blier P
Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
The Journal of pharmacology and experimental therapeutics 1998;285(2):404-12.
-
1998: Haddjeri N; De Montigny C; Curet O; Blier P
Effect of the reversible monoamine oxidase-A inhibitor befloxatone on the rat 5-hydroxytryptamine neurotransmission.
European journal of pharmacology 1998;343(2-3):179-92.
-
1997: Dong J; de Montigny C; Blier P
Effect of acute and repeated versus sustained administration of the 5-HT1A receptor agonist ipsapirone: electrophysiological studies in the rat hippocampus and dorsal raphe.
Naunyn-Schmiedeberg's archives of pharmacology 1997;356(3):303-11.
-
1997: Nishizawa S; Benkelfat C; Young S N; Leyton M; Mzengeza S; de Montigny C; Blier P; Diksic M
Differences between males and females in rates of serotonin synthesis in human brain.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(10):5308-13.
-
1997: Blier P; Bergeron R; de Montigny C
Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1997;16(5):333-8.
-
1997: Mongeau R; Blier P; de Montigny C
The serotonergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments.
Brain research. Brain research reviews 1997;23(3):145-95.
-
1997: Bergeron R; de Montigny C; Debonnel G
Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
British journal of pharmacology 1997;120(7):1351-9.
-
1997: Haddjeri N; de Montigny C; Blier P
Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.
British journal of pharmacology 1997;120(5):865-75.
-
1997: Haddjeri N; Blier P; de Montigny C
Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission.
Naunyn-Schmiedeberg's archives of pharmacology 1997;355(1):20-9.
-
1996: Debonnel G; Bergeron R; de Montigny C
Potentiation by dehydroepiandrosterone of the neuronal response to N-methyl-D-aspartate in the CA3 region of the rat dorsal hippocampus: an effect mediated via sigma receptors.
The Journal of endocrinology 1996;150 Suppl():S33-42.
-
1996: Haddjeri N; Blier P; de Montigny C
Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain.
The Journal of pharmacology and experimental therapeutics 1996;277(2):861-71.
-
1996: Debonnel G; Bergeron R; Monnet F P; De Montigny C
Differential effects of sigma ligands on the N-methyl-D-aspartate response in the CA1 and CA3 regions of the dorsal hippocampus: effect of mossy fiber lesioning.
Neuroscience 1996;71(4):977-87.
-
1996: Kasamo K; Blier P; De Montigny C
Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
The Journal of pharmacology and experimental therapeutics 1996;277(1):278-86.
-
1996: Hadrava V; Blier P; de Montigny C
Partial agonistic activity of R- and S-enantiomers of 8-OH-DPAT at 5-HT1A receptors.
Journal of psychiatry & neuroscience : JPN 1996;21(2):101-8.
-
1996: Bergeron R; de Montigny C; Debonnel G
Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(3):1193-202.
-
1996: Piñeyro G; de Montigny C; Weiss M; Blier P
Autoregulatory properties of dorsal raphe 5-HT neurons: possible role of electrotonic coupling and 5-HT1D receptors in the rat brain.
Synapse (New York, N.Y.) 1996;22(1):54-62.
-
1996: Debonnel G; de Montigny C
Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders.
Life sciences 1996;58(9):721-34.
-
1995: Haddjeri N; Blier P; de Montigny C
Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.
International clinical psychopharmacology 1995;10 Suppl 4():11-7.
-
1995: Piñeyro G; de Montigny C; Blier P
5-HT1D receptors regulate 5-HT release in the rat raphe nuclei. In vivo voltammetry and in vitro superfusion studies.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;13(3):249-60.
-
1995: Seletti B; Benkelfat C; Blier P; Annable L; Gilbert F; de Montigny C
Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1995;13(2):93-104.
-
1995: Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C
Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study.
Neuropharmacology 1995;34(10):1311-26.
-
1995: Bouchard P; Monnet F; Bergeron R; Roman F; Junien J L; de Montigny C; Debonnel G; Quirion R
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studies.
The European journal of neuroscience 1995;7(9):1952-62.
-
1995: Bergeron R; de Montigny C; Debonnel G
Biphasic effects of sigma ligands on the neuronal response to N-methyl-D-aspartate.
Naunyn-Schmiedeberg's archives of pharmacology 1995;351(3):252-60.
-
1995: Piñeyro G; Deveault L; de Montigny C; Blier P
Effect of prolonged administration of tianeptine on 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe.
Naunyn-Schmiedeberg's archives of pharmacology 1995;351(2):119-25.
-
1995: Piñeyro G; Deveault L; Blier P; Dennis T; de Montigny C
Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1995;351(2):111-8.
-
1994: Mongeau R; De Montigny C; Blier P
Effect of long-term administration of antidepressant drugs on the 5-HT3 receptors that enhance the electrically evoked release of [3H]noradrenaline in the rat hippocampus.
European journal of pharmacology 1994;271(1):121-9.
-
1994: Hadrava V; Blier P; de Montigny C
Agonist occupation of serotonin1A receptors in the rat hippocampus prevents their inactivation by pertussis toxin.
Neuroscience 1994;61(1):21-30.
-
1994: Blier P; de Montigny C
Current advances and trends in the treatment of depression.
Trends in pharmacological sciences 1994;15(7):220-6.
-
1994: Monnet F P; Debonnel G; Bergeron R; Gronier B; de Montigny C
The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
British journal of pharmacology 1994;112(2):709-15.
-
1994: de Montigny C
Lithium addition in treatment-resistant depression.
International clinical psychopharmacology 1994;9 Suppl 2():31-5.
-
1994: Mongeau R; de Montigny C; Blier P
Effects of long-term alpha-2 adrenergic antagonists and electroconvulsive treatments on the alpha-2 adrenoceptors modulating serotonin neurotransmission.
The Journal of pharmacology and experimental therapeutics 1994;269(3):1152-9.
-
1994: Piñeyro G; Blier P; Dennis T; de Montigny C
Desensitization of the neuronal 5-HT carrier following its long-term blockade.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1994;14(5 Pt 2):3036-47.
-
1994: Mongeau R; De Montigny C; Blier P
Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
European journal of pharmacology 1994;256(3):269-79.
-
1994: Mongeau R; de Montigny C; Blier P
Electrophysiologic evidence for desensitization of alpha 2-adrenoceptors on serotonin terminals following long-term treatment with drugs increasing norepinephrine synaptic concentration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1994;10(1):41-51.
-
1993: Dennis T; Blier P; de Montigny C
Delayed effects of spiperone on serotonin1A receptors in the dorsal hippocampus of rats.
Journal of psychiatry & neuroscience : JPN 1993;18(5):264-75.
-
1993: Bergeron R; Debonnel G; De Montigny C
Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands.
European journal of pharmacology 1993;240(2-3):319-23.
-
1993: Blier P; Lista A; De Montigny C
Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone.
The Journal of pharmacology and experimental therapeutics 1993;265(1):7-15.
-
1993: Blier P; Lista A; De Montigny C
Differential properties of pre- and postsynaptic 5-hydroxytryptamine1A receptors in the dorsal raphe and hippocampus: II. Effect of pertussis and cholera toxins.
The Journal of pharmacology and experimental therapeutics 1993;265(1):16-23.
-
1993: Mongeau R; Blier P; de Montigny C
In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus.
Naunyn-Schmiedeberg's archives of pharmacology 1993;347(3):266-72.
-
1993: Monnet F P; Debonnel G; de Montigny C
The cytochromes P-450 are not involved in the modulation of the N-methyl-D-aspartate response by sigma ligands in the rat CA3 dorsal hippocampus.
Synapse (New York, N.Y.) 1993;13(1):30-8.
-
1992: Monnet F P; Debonnel G; Fournier A; de Montigny C
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1219-25.
-
1992: Monnet F P; Fournier A; Debonnel G; de Montigny C
Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
The Journal of pharmacology and experimental therapeutics 1992;263(3):1212-8.
-
1992: Curet O; De Montigny C; Blier P
Effect of desipramine and amphetamine on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
European journal of pharmacology 1992;221(1):59-70.
-
1992: Monnet F P; Blier P; Debonnel G; de Montigny C
Modulation by sigma ligands of N-methyl-D-aspartate-induced [3H]noradrenaline release in the rat hippocampus: G-protein dependency.
Naunyn-Schmiedeberg's archives of pharmacology 1992;346(1):32-9.
-
1992: Monnet F P; Debonnel G; de Montigny C
In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands.
The Journal of pharmacology and experimental therapeutics 1992;261(1):123-30.
-
1992: Blier P; de Montigny C
Electrophysiological studies on the heterogeneity of 5-HT1A receptors: psychopharmacological implications.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():137A-138A.
-
1992: de Montigny C; Blier P
Potentiation of 5-HT neurotransmission by short-term lithium: in vivo electrophysiological studies.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():610A-611A.
-
1992: de Montigny C; Monnet F P; Fournier A; Debonnel G
Sigma ligands and neuropeptide Y selectively potentiate the NMDA response in the rat CA3 dorsal hippocampus: in vivo electrophysiological studies.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():145A-146A.
-
1991: Chaput Y; de Montigny C; Blier P
Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1991;5(4):219-29.
-
1991: Martial J; de Montigny C; Cecyre D; Quirion R
Characterization of 5-HT1D receptor binding sites in post-mortem human brain cortex.
Journal of psychiatry & neuroscience : JPN 1991;16(2):75-80.
-
1991: Blier P; Curet O; Chaput Y; de Montigny C
Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission.
Neuropharmacology 1991;30(7):691-701.
-
1991: Godbout R; Chaput Y; Blier P; de Montigny C
Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.
Neuropharmacology 1991;30(7):679-90.
-
1991: Lacroix D; Blier P; Curet O; de Montigny C
Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
The Journal of pharmacology and experimental therapeutics 1991;257(3):1081-90.
-
1991: Bouthillier A; Blier P; de Montigny C
Flerobuterol, a beta-adrenoceptor agonist, enhances serotonergic neurotransmission: an electrophysiological study in the rat brain.
Psychopharmacology 1991;103(3):357-65.
-
1990: de Montigny C; Chaput Y; Blier P
Modification of serotonergic neuron properties by long-term treatment with serotonin reuptake blockers.
The Journal of clinical psychiatry 1990;51 Suppl B():4-8.
-
1990: Debonnel G; de Montigny C
Hippocampal mossy fiber denervation induces a supersensitivity to cholecystokinin of CA3 pyramidal neurons in the guinea pig but not in the rat.
The Journal of pharmacology and experimental therapeutics 1990;254(3):1038-44.
-
1990: Lista A; Blier P; de Montigny C
Benzodiazepine receptors modulating serotonergic neurotransmission in rat hippocampus do not desensitize after long-term diazepam treatment.
Brain research 1990;526(1):161-4.
-
1990: Lista A; Blier P; de Montigny C
Benzodiazepine receptors modulate 5-hydroxytryptamine neurotransmission in the rat hippocampus: in vivo electrophysiological evidence.
The Journal of pharmacology and experimental therapeutics 1990;254(1):318-23.
-
1990: Monnet F P; Debonnel G; de Montigny C
Neuropeptide Y selectively potentiates N-methyl-D-aspartate-induced neuronal activation.
European journal of pharmacology 1990;182(1):207-8.
-
1990: Blier P; de Montigny C
Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies.
Journal of clinical psychopharmacology 1990;10(3 Suppl):13S-20S.
-
1990: Monnet F P; Debonnel G; Junien J L; De Montigny C
N-methyl-D-aspartate-induced neuronal activation is selectively modulated by sigma receptors.
European journal of pharmacology 1990;179(3):441-5.
-
1990: Blier P; de Montigny C; Chaput Y
A role for the serotonin system in the mechanism of action of antidepressant treatments: preclinical evidence.
The Journal of clinical psychiatry 1990;51 Suppl():14-20; discussion 21.
-
1990: Lista A; Blier P; De Montigny C
The benzodiazepine receptor inverse agonist DMCM decreases serotonergic transmission in rat hippocampus: an in vivo electrophysiological study.
Synapse (New York, N.Y.) 1990;6(2):175-8.
-
1990: Chaput Y; Lesieur P; de Montigny C
Effects of short-term serotonin depletion on the efficacy of serotonin neurotransmission: electrophysiological studies in the rat central nervous system.
Synapse (New York, N.Y.) 1990;6(4):328-37.
-
1990: Blier P; de Montigny C
Electrophysiological investigation of the adaptive response of the 5-HT system to the administration of 5-HT1A receptor agonists.
Journal of cardiovascular pharmacology 1990;15 Suppl 7():S42-8.
-
1989: Lista A; Blier P; De Montigny C
In vivo presynaptic modulation of serotonergic neurotransmission in the rat hippocampus by diazepam.
European journal of pharmacology 1989;171(2-3):229-31.
-
1989: Curet O; de Montigny C
Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. III. Evidence for the physiological role of terminal alpha 2-adrenergic autoreceptors.
Brain research 1989;499(1):18-26.
-
1989: Debonnel G; Weiss M; de Montigny C
Reduced neuroexcitatory effect of domoic acid following mossy fiber denervation of the rat dorsal hippocampus: further evidence that toxicity of domoic acid involves kainate receptor activation.
Canadian journal of physiology and pharmacology 1989;67(8):904-8.
-
1989: de Montigny C
Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.
Archives of general psychiatry 1989;46(6):511-7.
-
1989: Blier P; Steinberg S; Chaput Y; de Montigny C
Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus.
Canadian journal of physiology and pharmacology 1989;67(2):98-105.
-
1988: Curet O; de Montigny C
Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. I. Receptors mediating the effect of microiontophoretically applied norepinephrine.
Brain research 1988;475(1):35-46.
-
1988: Curet O; de Montigny C
Electrophysiological characterization of adrenoceptors in the rat dorsal hippocampus. II. Receptors mediating the effect of synaptically released norepinephrine.
Brain research 1988;475(1):47-57.
-
1988: Chaput Y; de Montigny C
Effects of the 5-hydroxytryptamine receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system.
The Journal of pharmacology and experimental therapeutics 1988;246(1):359-70.
-
1988: Bouthillier A; De Montigny C
Long-term benzodiazepine treatment reduces neuronal responsiveness to cholecystokinin: an electrophysiological study in the rat.
European journal of pharmacology 1988;151(1):135-8.
-
1988: Blier P; Chaput Y; de Montigny C
Long-term 5-HT reuptake blockade, but not monoamine oxidase inhibition, decreases the function of terminal 5-HT autoreceptors: an electrophysiological study in the rat brain.
Naunyn-Schmiedeberg's archives of pharmacology 1988;337(3):246-54.
-
1988: Debonnel G; de Montigny C
Increased neuronal responsiveness to cholecystokinin and dopamine induced by lesioning mesolimbic dopaminergic neurons: an electrophysiological study in the rat.
Synapse (New York, N.Y.) 1988;2(5):537-45.
-
1988: Blier P; de Montigny C; Chaput Y
Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission.
Clinical neuropharmacology 1988;11 Suppl 2():S1-10.
Sign-in to see more
